Association between Quantitative Serum HBsAg Level and Therapeutic Response to Entecavir in Patients with Chronic Hepatitis B

被引：0
|
作者：
Peng, Cheng-Yuan [1 ]
Lai, Hsueh-Chou [1 ]
Su, Wen-Pang [1 ]
Lin, Chia-Hsin [1 ]
Chuang, Po-Heng [1 ]
Kao, Jung-Ta [1 ]
Chen, Sheng-Hung [1 ]
机构：
[1] China Med Univ Hosp, Dept Internal Med, Div Hepatogastroenterol, Taichung, Taiwan
来源：
HEPATOLOGY | 2012年 / 56卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
360
引用
收藏
页码：367A / 368A
页数：2
相关论文
共 50 条
  • [31] The change of the quantitative HBsAg level during the natural course of chronic hepatitis B
    Kim, Yu J.
    Cho, Hyun C.
    Choi, Moon S.
    Lee, Joon H.
    Koh, Kwang C.
    Yoo, Byung C.
    Paik, Seung W.
    LIVER INTERNATIONAL, 2011, 31 (06) : 819 - 825
  • [32] Low serum HBsAg level predicts HBsAg seroclearance and sustained response in chronic hepatitis B after stopping oral NUCs
    Leerapun, Apinya
    Pinyomahakul, Piyakiat
    Kijdamrongthum, Phuripong
    Chitapanarux, Taned
    Thongsawat, Satawat
    HEPATOLOGY, 2016, 64 : 915A - 915A
  • [33] Association between mitochondrial DNA content and baseline serum levels of HBsAg in chronic hepatitis B infection
    Chen, Tianbin
    Xun, Zhen
    Lin, Jinpiao
    Fu, Ya
    Wu, Wennan
    Fu, Xiaochun
    Hu, Yuhai
    Zeng, Yongbin
    Ou, Qishui
    JOURNAL OF MEDICAL VIROLOGY, 2017, 89 (11) : 1958 - 1962
  • [34] Assessing the Durability of Entecavir-Treated Hepatitis B Using Quantitative HBsAg
    Wang, Chia-Chi
    Tseng, Kuo-Chih
    Hsieh, Tsai-Yuan
    Tseng, Tai-Chung
    Lin, Hans Hsienhong
    Kao, Jia-Horng
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 (09): : 1286 - 1294
  • [35] Low serum HBsAg and HBV DNA predict response of peg-interferon addition to entecavir in HBeAg positive chronic hepatitis B
    Liem, S.
    Hansen, B.
    Xie, Q.
    Liang, C.
    Brouwer, W. P.
    Chi, H.
    Guo, S.
    Qi, X.
    Zhang, N. -P.
    Fehmi, T.
    Campenhout, M. V.
    Janssen, H.
    JOURNAL OF HEPATOLOGY, 2018, 68 : S518 - S519
  • [36] Relationship between HBV DNA load and levels of serum HBsAg in patients with chronic hepatitis B
    Zhu, H. -Y.
    Zhang, X. -S.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2016, 20 (10) : 2061 - 2064
  • [37] Hepatocyte HBcAg and HBsAg expressions as markers for predicting response to entecavir treatment in chronic hepatitis B infection
    Yim, Sun Young
    Um, Soon Ho
    Seo, Yeon Seok
    Jeen, Yoon Tae
    Keum, Bora
    Lee, Hong Sik
    Chun, Hoon Jai
    Yim, Hyung Joon
    Kim, Ji Hoon
    Kim, Chang Duck
    Yoon, Seok Bae
    Yun, Tae Jung
    Ryu, Ho Sang
    HEPATOLOGY, 2013, 58 : 652A - 652A
  • [38] CAN SERUM LEVEL OF HEPATITIS B SURFACE ANTIGEN (HBsAg) DIFFERENTIATE HBsAg INACTIVE CARRIER STATE FROM CHRONIC HEPATITIS B?
    Keshvari, M.
    Sali, S.
    Sharafi, H.
    Alavian, S. Hoda
    Alavian, S. Moayed
    Etesam, F.
    Salimi, S.
    Merza, M. A.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S539 - S539
  • [39] HBsAg seroconversion: Different kinetics of serum HBsAg level decrease in inactive carriers and chronic hepatitis B patients treated with interferon
    Moucari, Rami
    Mackiewicz, Vincent
    Lada, Olivier
    Devergne, Agnes
    Boyer, Nathalie
    Asselah, Tarik
    Martinot-Peignoux, Michele
    Vidaud, Michel
    Nicolas-Chanoine, Marie-Helene
    Marcellin, Patrick
    HEPATOLOGY, 2007, 46 (04) : 680A - 680A
  • [40] Response to tenofovir monotherapy in chronic hepatitis B patients with prior suboptimal response to entecavir
    Pan, C. Q.
    Hu, K. -Q.
    Yu, A. S.
    Chen, W.
    Bunchorntavakul, C.
    Reddy, K. R.
    JOURNAL OF VIRAL HEPATITIS, 2012, 19 (03) : 213 - 219
12345